In the global fight against COVID-19, while most Chinese manufacturers are stepping up efforts to provide medical devices, traditional Chinese medicine enterprises too are helping the world combat the pandemic.
China Traditional Chinese Medicine Holdings Co Ltd, a subsidiary of Sinopharm Group, donated medical supplies worth 400,000 yuan ($56,800) to help fight the deadly contagion in Italy and France.
Shijiazhuang Yiling Pharmaceutical donated Lianhuaqingwen capsules worth 1.78 million yuan to aid Iraq in contagion prevention and control efforts. The compound herbal medicine has proved to be effective in treating COVID-19.
The National Health Commission said that by the end of March, 91.5 percent of confirmed COVID-19 cases that used TCM treatment combined with Western medicine saw effective rates of over 90 percent.
“TCM treatment has become a bright spot of China’s pandemic prevention and control,” said Yu Yanhong, a member of the National Health Commission Party Leadership Group and Party secretary of the National Administration of Traditional Chinese Medicine.
At the end of March, Yiling’s Lianhuaqingwen capsules received registration approval from the Thailand Ministry of Public Health, allowing the company to sell the products in the Thai market. Previously, it has obtained marketing authorization in Brazil, Indonesia, Canada, Mozambique and Romania.
However, exporting TCM as a contagion prevention and control remedy has not been without difficulties. Industry experts noted that in some countries where TCM is not recognized by local medical laws and regulations, such products are not allowed to be used in local hospitals. In such instances, TCM donated by Chinese firms has mostly been used as preventive treatment...
Full text at GMPnews.Net